In regulated life-science products, labeling includes all printed and graphical information on or accompanying a product, such as labels, outer packaging, instructions for use, and patient leaflets, as well as electronic instructions. Localization of labeling is a controlled process because it must preserve safety messages, indications, warnings, and regulatory symbols across languages; labeling changes often require formal documented update workflows.
Translators encounter labeling in packaging artwork, instructions for use, patient information leaflets, IFUs, and regulatory submissions. The work often involves layout constraints, symbol preservation, and terminology checks against approved source text. Changes must be tracked because labeling is subject to review by notified bodies or health authorities. Multilingual labeling may require country-specific statements.
A common error is translating warnings or precautions more softly than the source text, or placing them in a less visible area. Translators may also render a device label's symbol glossary incorrectly or omit country-specific legal text. These mistakes can create noncompliance and patient safety risks. Even wording changes that seem stylistic may alter intended use.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →